ImmuneOnco Biopharmaceuticals (Shanghai) Inc

01541

Company Profile

  • Business description

    ImmuneOnco Biopharmaceuticals (Shanghai) Inc is a science-driven biotechnology company dedicated to the development of immuno-oncology therapies. It is one of the few biotechnology companies globally adopting a systematic approach to harness both the innate and adaptive immune systems. It has developed a rich pipeline of 14 drug candidates with eight ongoing clinical programs, featured by a comprehensive innate-immunity-based asset portfolio. Its pipeline reflects its extensive understanding of the frontiers of cancer biology and immunology and its expertise in turning scientific research into drug candidates.

  • Contact

    1000 Zhangheng Road
    Unit 15, China (Shanghai) Pilot Free Trade Zone
    Pudong New Area
    Shanghai
    CHN

    T: +86 2138016387

    https://cn.immuneonco.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    156

Stocks News & Analysis

stocks

Undervalued ASX share showing progress in global efforts

More clarity on the path forward in the UK.
stocks

Bookworm: Is this the secret to exceptional long-term returns?

Acceptance may be an investor’s best friend.
stocks

Unconventional wisdom: Are dividends the answers?

As investors toil in complexity the obvious solution may be the right one.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,964.2029.900.33%
CAC 407,834.5816.300.21%
DAX 4024,217.5078.43-0.32%
Dow JONES (US)44,901.92208.010.47%
FTSE 1009,120.3118.06-0.20%
HKSE25,510.31121.960.48%
NASDAQ21,108.3250.360.24%
Nikkei 22541,042.20414.03-1.00%
NZX 50 Index12,910.7457.280.45%
S&P 5006,388.6425.290.40%
S&P/ASX 2008,698.7031.800.37%
SSE Composite Index3,594.400.740.02%

Market Movers